2792 participants
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-20
- Start Date:
- 2008-04-25
- Completion:
- 2010-05-06
Conditions
- Urinary Bladder, Overactive
Interventions
- DRUG